By Benjamin Livingston : NPS Pharmaceuticals (NASDAQ: NPSP ) is a biopharmaceutical that ..... With this strategy in mind, NPSP develops drugs that will, in ..... company has to offer. In addition, NPSP receives royalties from numerous
By Dr. Paul Nunzio De Santis, Pharm.D : Please see Shire's website here for LSE to ADR share conversion methodology. Investment Thesis With SHPG trading currently at ~21x 2015E and ample capacity to grow through acquisitions, we expect SHPG to preserve its current takeover premium through the July
The U.S. regulator approves new labeling for NPS Pharmaceuticals ' ( NPSP ) Gattex ( teduglutide [rDNA origin]) for injection to include long-term data from the STEPS 2 clinical trial of adult patients
Pharmaceuticals International, Inc. (U.S. Shares) (2.19%), AstraZeneca PLC (ADR) (1.78%) and NPS Pharmaceuticals , Inc. (1.74%). There are no assurances that any Janus portfolio currently holds these securities or other
(Reuters) - U.S. drug reviewers found three serious concerns related to NPS Pharmaceuticals Inc's experimental drug for short bowel syndrome but said they did not think the drug needed to be...